CSIMarket
 


Pro Dex Inc  (PDEX)
Other Ticker:  
 
 

PDEX's Capital Expenditures Growth by Quarter and Year

Pro Dex Inc's Capital Expenditures results by quarter and year




PDEX Capital Expenditures (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter June - 0.34 0.10 0.09
III Quarter March 0.11 0.51 0.10 0.18
II Quarter December 0.26 0.08 0.58 0.05
I Quarter September 0.06 0.48 0.15 0.33
FY   0.43 1.41 0.93 0.65



PDEX Capital Expenditures third quarter 2020 Y/Y Growth Comment
Pro Dex Inc reported drop in Capital Expenditures in the third quarter by -79.41% to $ 0.11 millions, from the same quarter in 2019.
The fall in the third quarter Pro Dex Inc's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures rise of 20.54%.

Looking into third quarter results within Medical Equipment & Supplies industry 53 other companies have achieved higher Capital Expenditures growth. While Pro Dex Inc' s Capital Expenditures meltdown of -79.41% ranks overall at the positon no. 1381 in the third quarter.




PDEX Capital Expenditures ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter June - 240 % 11.11 % -60.87 %
III Quarter March -79.41 % 410 % -44.44 % 100 %
II Quarter December 225 % -86.21 % 1060 % 150 %
I Quarter September -87.5 % 220 % -54.55 % -
FY   - 51.61 % 43.08 % 91.18 %

Financial Statements
Pro Dex Inc's third quarter 2020 Capital Expenditures $ 0.11 millions PDEX's Income Statement
Pro Dex Inc's third quarter 2019 Capital Expenditures $ 0.51 millions Quarterly PDEX's Income Statement
New: More PDEX's historic Capital Expenditures Growth >>


PDEX Capital Expenditures (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter June - -33.33 % 0 % -50 %
III Quarter March -59.62 % 537.5 % -82.76 % 260 %
II Quarter December 333.33 % -83.33 % 286.67 % -84.85 %
I Quarter September -82.35 % 380 % 66.67 % 43.48 %
FY (Year on Year)   - 51.61 % 43.08 % 91.18 %




Capital Expenditures third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #54
Healthcare Sector #220
Overall #1381

Capital Expenditures Y/Y Growth Statistics
High Average Low
172.36 % 20.54 % -73.21 %
(June 30. 2016)   (Dec 31 2015)
Capital Expenditures third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #54
Healthcare Sector #220
Overall #1381
Capital Expenditures Y/Y Growth Statistics
High Average Low
172.36 % 20.54 % -73.21 %
(June 30. 2016)   (Dec 31 2015)

Capital Expenditures by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Pro Dex Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
2000 % 153.77 % -93.75 %
(Dec 31 2015)  


PDEX's III. Quarter Q/Q Capital Expenditures Comment
In the III. Quarter 2020 Pro Dex Inc reported fall in Capital Expenditures sequentially by -59.62% to $ 0.11 millions, from $ 0.26 millions achived a quarter before.

Although periodic influence normally fuel III. Quarter 2020 results, it plainly was not sufficient to recover PDEX's III. Quarter 2020 outcome, Arianna W. Young, market contributor pointed out and mentioned that average quarter on quarter Capital Expenditures growth is at 153.77% for PDEX.

Within Medical Equipment & Supplies industry 48 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Pro Dex Inc's Capital Expenditures growth quarter on quarter, overall rank is 1206.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #49
Healthcare Sector #190
Overall #1206
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #49
Healthcare Sector #190
Overall #1206
Capital Expenditures Q/Q Growth Statistics
High Average Low
2000 % 153.77 % -93.75 %
(Dec 31 2015)  


PDEX's III. Quarter Q/Q Capital Expenditures Comment
In the III. Quarter 2020 Pro Dex Inc reported fall in Capital Expenditures from the previous quarter by -59.62% to $ 0.11 millions, from $ 0.26 millions released in the previous qaurter.

Those seasonal factors which commonly energize III. Quarter 2020 Capital Expenditures, could not rescue the III. Quarter for the Pro Dex Inc, Arianna W. Young, market contributor pointed out, she detected new headwinds down the road for PDEX and continued that average quarter on quarter Capital Expenditures growth is at 153.77% for PDEX.

Within Medical Equipment & Supplies industry 48 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Pro Dex Inc's Capital Expenditures growth quarter on quarter, overall rank is 1206.


Pro Dex Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Capital Expenditures 12 Months Ending $ 0.76 $ 1.16 $ 0.98 $ 1.40 $ 1.16
Y / Y Capital Expenditures Growth (TTM) -34.51 % 52.76 % -22.31 % 49.68 % 26.72 %
Year on Year Capital Expenditures Growth Overall Ranking # 1170 # 77 # 1263 # 711 # 1063
Seqeuential Capital Expenditures Change (TTM) -34.45 % 18.23 % -29.76 % 20.31 % 52.89 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1381 # 253 # 1715 # 531 # 167




Cumulative Capital Expenditures growth Comment
For the 12 months ended Mar 31 2020 Pro Dex Inc reported a drop in Capital Expenditures by -34.51% year on year, to $1 millions, compare to the 52.76% growth at Dec 31 2019.

In the Healthcare sector 163 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 77 to 1170.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
172.36 %
20.54 %
-73.21 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 54
Healthcare Sector # 164
Overall # 1170

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
1048.33 %
109.24 %
-83.78 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 54
Sector # 220
S&P 500 # 1381
Cumulative Capital Expenditures growth Comment
For the 12 months ended Mar 31 2020 Pro Dex Inc reported a drop in Capital Expenditures by -34.51% year on year, to $1 millions, compare to the 52.76% growth at Dec 31 2019.

In the Healthcare sector 163 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 77 to 1170.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
172.36 %
20.54 %
-73.21 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 54
Healthcare Sector # 164
Overall # 1170

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
1048.33 %
109.24 %
-83.78 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 54
Sector # 220
S&P 500 # 1381




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
PDEX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for PDEX's Competitors
Capital Expenditures Growth for Pro Dex Inc's Suppliers
Capital Expenditures Growth for PDEX's Customers

You may also want to know
PDEX's Annual Growth Rates PDEX's Profitability Ratios PDEX's Asset Turnover Ratio PDEX's Dividend Growth
PDEX's Roe PDEX's Valuation Ratios PDEX's Financial Strength Ratios PDEX's Dividend Payout Ratio
PDEX's Roa PDEX's Inventory Turnover Ratio PDEX's Growth Rates PDEX's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2020
Orasure Technologies Inc -1.26 %$ -1.256 millions
Beigene Ltd -1.35 %$ -1.351 millions
Spero Therapeutics Inc -2.47 %$ -2.469 millions
Neuronetics Inc -2.92 %$ -2.920 millions
Myriad Genetics Inc -3.23 %$ -3.226 millions
Celcuity Inc -4.28 %$ -4.276 millions
Kaleido Biosciences Inc -4.53 %$ -4.529 millions
Standard Diversified Inc -4.67 %$ -4.674 millions
Johnson and Johnson -4.73 %$ -4.726 millions
Fibrogen Inc -4.97 %$ -4.969 millions
Vanda Pharmaceuticals Inc -5.09 %$ -5.089 millions
Tenet Healthcare Corp -5.15 %$ -5.155 millions
Hanger Inc -5.38 %$ -5.379 millions
Biolife Solutions Inc -6.41 %$ -6.410 millions
Endologix Inc -6.54 %$ -6.542 millions
Kyto Technology and Life Science Inc -7.82 %$ -7.819 millions
Intuitive Surgical Inc -8.36 %$ -8.362 millions
Bristol Myers Squibb Co -8.82 %$ -8.824 millions
Dynatronics Corp -8.92 %$ -8.923 millions
Integrated Biopharma Inc -9.52 %$ -9.524 millions
Viveve Medical Inc -10.06 %$ -10.056 millions
Heska Corp -10.26 %$ -10.256 millions
Icu Medical Inc -10.45 %$ -10.447 millions
Milestone Scientific Inc -11.92 %$ -11.920 millions
Veracyte Inc -13.07 %$ -13.072 millions
Baxter International Inc -13.13 %$ -13.131 millions
Eventbrite Inc -13.22 %$ -13.215 millions
Blueprint Medicines Corporation -13.84 %$ -13.842 millions
Dexcom Inc -15.52 %$ -15.522 millions
Bionik Laboratories Corp -15.58 %$ -15.577 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TRILINC's Profile

Stock Price

TRILINC's Financials

Business Description

Fundamentals

Charts & Quotes

TRILINC's News

Suppliers

TRILINC's Competitors

Customers & Markets

Economic Indicators

TRILINC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071